Aflac Innovation Partners

The firm relies on Aflac’s corporate relationships in Japan and the U.S., tapping insurance distribution networks, broker channels, and the parent’s healthcare partnerships to surface technology investments. It does not publicly disclose a proprietary sourcing model or use an external advisory network.

Available evidence points solely to direct equity investments in private companies. Aflac Innovation Partners has not reported any fund-of-funds allocations or LP commitments to outside venture managers.

The unit is a wholly owned corporate venture subsidiary of Aflac Incorporated, the New York Stock Exchange–listed insurance holding company. It invests the parent’s balance sheet capital and does not accept external limited partners, making its returns and risk parameters internal to Aflac’s overall treasury management.

The partnership concentrates on digital health, insurtech, employee benefits platforms, and enterprise software with applications to the insurance value chain. It has not publicly tagged specific verticals as out of scope, but the parent’s insurance focus suggests healthcare services and financial infrastructure are core.

Aflac Innovation Partners does not publicly identify its managing directors or investment committee members. Decision-making authority likely rests with Aflac Incorporated’s corporate development or strategy leads, based in part in Tokyo, but the exact governance structure is not disclosed.